Avisa Maleki

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Computational Biology

Tumor Classification

Top Venues

Publications

Giulia Russo, Elena Crispino, Avisa Maleki, Valentina Di Salvatore, Filippo Stanco, Francesco Pappalardo
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza. BMC Bioinform. 24 (1) (2023)
Avisa Maleki, Alvaro Ras-Carmona, Elena Crispino, Valentina Di Salvatore, Giulia Russo, Pedro A. Reche, Francesco Pappalardo
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective. BIBM (2023)
Elena Crispino, Giulia Russo, Maria Adelaida Gomez, Francesco Pappalardo, Avisa Maleki, Valentina Di Salvatore
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator. BIBM (2023)
Avisa Maleki, Alvaro Ras-Carmona, Valentina Di Salvatore, Giulia Russo, Elena Crispino, Francesco Pappalardo
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern. BIBM (2022)
Nandu Chandran Nair, Elena Crispino, Avisa Maleki, Valentina Di Salvatore, Giulia Russo, Maria Adelaida Gomez, Francesco Pappalardo
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator. BIBM (2022)
Giuseppe Alessandro Parasiliti Palumbo, Avisa Maleki, Serena Anna Italia, Giulia Russo, Francesco Pappalardo
Uncertainty quantification and sensitivity analysis for in silico trial platform: a preliminary application on UISS-MS. BIBM (2021)
Valentina Di Salvatore, Avisa Maleki, Giulia Russo, Giuseppe Sgroi, Giuseppe Alessandro Parasiliti Palumbo, Francesco Pappalardo
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant. BIBM (2021)
Avisa Maleki, Giulia Russo, Giuseppe Alessandro Parasiliti Palumbo, Francesco Pappalardo
In silico design of recombinant multi-epitope vaccine against influenza A virus. BMC Bioinform. (14) (2021)